← Back to All Filings

Precision Biosciences Officer Plans Minor Stock Sale for Taxes

Low SignificanceNovember 3, 2025 at 3:32:10 PM EST

PRECISION BIOSCIENCES INC

$DTIL144CIK: 0001357874

Subscribe to track DTIL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Precision Biosciences Officer Plans Minor Stock Sale for Taxes

Company: PRECISION BIOSCIENCES INC (DTIL) Form: 144 | Filed: 2025-11-03 Significance: Low

Insider: Scimeca Dario Title: Not Specified | Relationship: Officer

Transaction (Proposed): • Type: Sell (to cover taxes) • Shares: 665 • Value: ~$4,315

Key Insight: This is a proposed sale to cover tax obligations resulting from a vested equity award. Such non-discretionary sales are common and typically hold low trading significance as they do not reflect a change in the insider's outlook on the company.

Market Context: The transaction value represents less than 0.005% of the company's $100M market capitalization and is considered immaterial.

Comprehensive Analysis

SEC Filing Analysis: PRECISION BIOSCIENCES INC (DTIL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Precision Biosciences has filed a notice of a proposed sale of 665 shares, valued at approximately $4,315, to cover tax liabilities from vested stock awards.
  • Market Impact: This transaction is considered routine and non-discretionary, with a negligible impact on the market.

Company Information

FieldValue
CompanyPRECISION BIOSCIENCES INC
Ticker SymbolDTIL
CIK0001357874
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameScimeca Dario
CIK0001779581
Title/PositionNot Specified
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-03 (Approximate)
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved665
Price Per Share~$6.49
Total Value$4,315.19
Shares Owned AfterNot Specified
Ownership TypeNot Specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,315.19
% of Market Cap0.004%
Shares Transacted665
% of Shares Outstanding0.006%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $100 million, this transaction of ~$4,315 is financially insignificant.
  • Transaction Significance: The sale represents a negligible fraction of both the company's market capitalization and its total shares outstanding, falling far below any threshold for significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing is a Form 144 notice for a proposed sale intended to cover tax obligations. These 'sell-to-cover' transactions are automated and not indicative of an insider's sentiment towards the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market generally disregards minor, non-discretionary tax-related sales.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's remarks explicitly state, "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." This confirms the non-discretionary nature of the sale.
Topics:#SECFiling#InsiderTrading#DTIL#PrecisionBiosciences#Form144#StockSale#Biotech#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.